Steris hit with FDA warning letter

Steris' struggles with the FDA continue. The agency cited the company for making improper marketing claims about several steam-sterilization devices. The Feb. 9 warning letter alleges the Mentor, Ohio-based company misbranded its devices by making claims about their capabilities that were not cleared by the FDA as part of Steris' 510(k) applications. News

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.